UCSF 22nd Annual Osteoporosis New Insights in Research, Diagnosis, and Clinical Care 2025

UCSF 22nd Annual Osteoporosis New Insights in Research, Diagnosis, and Clinical Care 2025

Include: 2 videos + 10 pdfs, size: 4.41 GB
Target Audience: endocrinologists, geriatricians, rheumatologists, primary care providers
Information:

Now in its 22nd year, and presented by the Department of Epidemiology and Biostatistics of the University of California, San Francisco School of Medicine, this 1-day virtual course features an expert faculty that will discuss the epidemiology, pathophysiology, diagnosis, and treatment of osteoporosis. The course will critically review current treatment options. There will be an emphasis on recent developments and current controversies in the etiology, diagnosis, and management of osteoporosis. Additional special topics this year include exercise for fall and fracture prevention, nutrition and skeletal health, and the approach to the premenopausal woman with low bone mass or skeletal fragility.

TARGET AUDIENCE
The course will provide an update on current recommendations about screening and treatment of osteoporosis for health care providers working with osteoporosis patients. It will also benefit researchers, technologists, and pharmaceutical or device company professionals who would find additional scientific background in the disease helpful. No prior clinical or scientific training in osteoporosis is required.

OBJECTIVES

• Screen for and diagnose osteoporosis according to the latest evidence-based standards of care;
• Interpret dual-energy X-ray absorptiometry (DXA) bone density scans and avoid common DXA pitfalls;
• Provide appropriate pharmacological treatment for osteoporosis, including antiresorptive and anabolic therapies;
• Assess the benefits and risks of continuing long-term antiresorptive osteoporosis therapy and determine optimal treatment duration;
• Recommend physical activity to optimize bone health and to help patients with skeletal fragility move safely;
• Provide evidence-based nutritional guidance for healthy bones;
• Evaluate and treat, when appropriate, the premenopausal woman with low bone mass or skeletal fragility

 

Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

Thursday, July 31, 2025
SCREENING AND DIAGNOSIS
8:00 AM		Zoom Registration and login, housekeeping, overview
8:10	G	Osteoporosis Screening and Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis	Steven T. Harris, MD, FACP, FASBMR
8:50		Q&A
ANTIRESORPTIVE TREATMENT
9:00	G	Bisphosphonate Efficacy, Duration, and Drug Holidays: Maximize Benefits and Minimize Risk	Dennis M. Black, PhD
9:30		Q&A
9:40	G	Long-Term Treatment With and Following Denosumab	Karin Y. Wu, MD
10:10		Q&A
10:20		Break
ANABOLIC TREATMENT
10:35	G	Anabolic and Mixed Anabolic/Antiresorptive Agents: When, and How, and In Whom to Use Them	Kelly Wentworth, MD
11:05		Q&A
11:15	G	Long-Term Monitoring and Management of Bone Health	Anne L. Schafer, MD
11:45		Q&A with the Panel of Morning Speakers	Kelly Wentworth, MD Anne L. Schafer, MD Karin Y. Wu, MD Dennis M. Black, PhD Steven T. Harris, MD, FACP, FASBMR Deborah E. Sellmeyer, MD (facilitator)
12:20 PM		Lunch Break (Zoom Livestream Closed During This Time)
SPECIAL TOPICS IN OSTEOPOROSIS
1:20 PM	G	Nutrition and Skeletal Health	Deborah E. Sellmeyer, MD
1:50		Q&A
2:00	G	Exercise for Fall and Fracture Prevention	Lora Giangregorio, PhD
2:30		Q&A
2:40		DXA Interpretation and Pitfalls	Deborah E. Sellmeyer, MD
3:10		Q&A
3:20		Break
3:35	G	Approach to the Premenopausal Woman with Low Bone Mass or Skeletal Fragility	Yumie Rhee, MD
4:05		Q&A
4:15	G	Clinical Roundtable: Q&A with a Panel of Physicians	Steven T. Harris, MD, FACP, FASBMR Deborah E. Sellmeyer, MD Karin Y. Wu, MD Tiffany Y. Kim, MD Anne L. Schafer, MD (facilitator)
5:00		Adjourn